Oxygen Mapping within Healthy and Acutely Infarcted Brain Tissue in Humans Using the NMR Relaxation of Lipids: A Proof-Of-Concept Translational Study.
The clinical applicability of brain oxygenation mapping using the MOBILE (Mapping of Oxygen By Imaging Lipids relaxation Enhancement) magnetic resonance (MR) technique was assessed in the clinical setting of normal brain and of acute cerebral ischemia as a founding proof-of-concept translational study. Changes in the oxygenation level within healthy brain tissue can be detected by analyzing the spin-lattice proton relaxation ('Global T1' combining water and lipid protons) because of the paramagnetic properties of molecular oxygen. It was hypothesized that selective measurement of the relaxation of the lipid protons ('Lipids T1') would result in enhanced sensitivity of pO2 mapping because of higher solubility of oxygen in lipids than in water, and this was demonstrated in pre-clinical models using the MOBILE technique. In the present study, 12 healthy volunteers and eight patients with acute (48-72 hours) brain infarction were examined with the same clinical 3T MR system. Both Lipids R1 (R1 = 1/T1) and Global R1 were significantly different in the infarcted area and the contralateral unaffected brain tissue, with a higher statistical significance for Lipids R1 (median difference: 0.408 s-1; p<0.0001) than for Global R1 (median difference: 0.154 s-1; p = 0.027). Both Lipids R1 and Global R1 values in the unaffected contralateral brain tissue of stroke patients were not significantly different from the R1 values calculated in the brain tissue of healthy volunteers. The main limitations of the present prototypic version of the MOBILE sequence are the long acquisition time (4 min), hampering robustness of data in uncooperative patients, and a 2 mm slice thickness precluding accurate measurements in small infarcts because of partial volume averaging effects.
Biomedical Magnetic Resonance Group, Louvain Drug Research Institute, Université Catholique de Louvain (UCL), Brussels, Belgium.
Florence
F
Colliez
Department of Radiology and Medical Imaging, Cliniques universitaires UCL-Saint-Luc, Brussels, Belgium.
Marta M
MM
Safronova
Biomedical Magnetic Resonance Group, Louvain Drug Research Institute, Université Catholique de Louvain (UCL), Brussels, Belgium.
Julie
J
Magat
Biomedical Magnetic Resonance Group, Louvain Drug Research Institute, Université Catholique de Louvain (UCL), Brussels, Belgium.
Nicolas
N
Joudiou
Department of Neurology, Cliniques universitaires UCL-Saint-Luc, Brussels, Belgium.
André P
AP
Peeters
Biomedical Magnetic Resonance Group, Louvain Drug Research Institute, Université Catholique de Louvain (UCL), Brussels, Belgium.
Bénédicte F
BF
Jordan
Biomedical Magnetic Resonance Group, Louvain Drug Research Institute, Université Catholique de Louvain (UCL), Brussels, Belgium.
Bernard
B
Gallez
Department of Radiology and Medical Imaging, Cliniques universitaires UCL-Saint-Luc, Brussels, Belgium.
Thierry
T
Duprez
D001921:Brain / Q000378:metabolism / Q000502:physiology* / Q000503:physiopathology; D020520:Brain Infarction / Q000175:diagnosis*; D016022:Case-Control Studies; D006801:Humans; D050356:Lipid Metabolism; D008279:Magnetic Resonance Imaging / Q000379:methods*; D010100:Oxygen / Q000378:metabolism; D011522:Protons
D011522:Protons; D010100:Oxygen